Cleveland Diagnostics

About:

Cleveland Diagnostics is a diagnostics company developing efficacious, affordable diagnostics tests to improve cancer diagnostics.

Website: http://www.clevelanddx.com

Top Investors: Novo Holdings, Cleveland Clinic, Symbolic Capital, LYFE Capital, Genomic Health

Description:

Cleveland Diagnostics is a commercial-stage diagnostics company developing efficacious, lab-friendly, affordable diagnostics tests using proprietary technology to improve cancer diagnostics. Its solvent interaction analysis technology investigates protein biomarkers at the structural level, providing better and more direct insights regarding the protein origin on the cellular level, thus improving test specificity to the underlying disease process. Its portfolio of non-invasive cancer diagnostics will be expanding from prostate cancer to breast cancer and lung cancer, and certain neurological diseases.

Total Funding Amount:

$111M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cleveland, Ohio, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)clevelanddx.com

Founders:

Arnon Chait, Boris Zaslavsky

Number of Employees:

51-100

Last Funding Date:

2024-01-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai